An improved ultrafiltration method for determining free testosterone in serum. 1982

I Vlahos, and W MacMahon, and D Sgoutas, and W Bowers, and J Thompson, and W Trawick

In this method, we use the Amicon MPS-1 centrifugal ultrafiltration device and the YMB membrane in measuring free testosterone in serum. Two independent assays are combined: total testosterone and the ultrafiltrable fraction of added [3H]testosterone. The unbound fraction is determined in 0.15-0.5 mL ultrafiltrates of 0.6 to 1 mL of variably diluted serum that has been equilibrated with [3H]testosterone at 37 degrees C. The assay is rapid (less than 1 h), practicable (requires 0.6 mL of serum), and reproducible (CV 3.2% within assay, 3.9% between assays). Accuracy was evaluated as the fraction of free testosterone in the ultrafiltrate of dialyzed serum vs that in a prior dialysate; they were the same confirming the validity of the free testosterone measurement. Samples from ostensibly healthy men and women and from hirsute and pregnant women gave results that agreed with those obtained by equilibrium dialysis. Total testosterone concentrations for normal and hirsute women showed considerable overlap, but data on free testosterone concentrations in these populations were better resolved.

UI MeSH Term Description Entries
D007202 Indicators and Reagents Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant & Hackh's Chemical Dictionary, 5th ed, p301, p499) Indicator,Reagent,Reagents,Indicators,Reagents and Indicators
D008297 Male Males
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D005260 Female Females
D006628 Hirsutism A condition observed in WOMEN and CHILDREN when there is excess coarse body hair of an adult male distribution pattern, such as facial and chest areas. It is the result of elevated ANDROGENS from the OVARIES, the ADRENAL GLANDS, or exogenous sources. The concept does not include HYPERTRICHOSIS, which is an androgen-independent excessive hair growth.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013739 Testosterone A potent androgenic steroid and major product secreted by the LEYDIG CELLS of the TESTIS. Its production is stimulated by LUTEINIZING HORMONE from the PITUITARY GLAND. In turn, testosterone exerts feedback control of the pituitary LH and FSH secretion. Depending on the tissues, testosterone can be further converted to DIHYDROTESTOSTERONE or ESTRADIOL. 17-beta-Hydroxy-4-Androsten-3-one,17-beta-Hydroxy-8 alpha-4-Androsten-3-one,8-Isotestosterone,AndroGel,Androderm,Andropatch,Androtop,Histerone,Sterotate,Sustanon,Testim,Testoderm,Testolin,Testopel,Testosterone Sulfate,17 beta Hydroxy 4 Androsten 3 one,17 beta Hydroxy 8 alpha 4 Androsten 3 one,8 Isotestosterone
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D014316 Tritium The radioactive isotope of hydrogen also known as hydrogen-3. It contains two NEUTRONS and one PROTON in its nucleus and decays to produce low energy BETA PARTICLES. Hydrogen-3,Hydrogen 3

Related Publications

I Vlahos, and W MacMahon, and D Sgoutas, and W Bowers, and J Thompson, and W Trawick
November 1987, Nihon Naibunpi Gakkai zasshi,
I Vlahos, and W MacMahon, and D Sgoutas, and W Bowers, and J Thompson, and W Trawick
January 1980, Clinical chemistry,
I Vlahos, and W MacMahon, and D Sgoutas, and W Bowers, and J Thompson, and W Trawick
November 1980, Clinical chemistry,
I Vlahos, and W MacMahon, and D Sgoutas, and W Bowers, and J Thompson, and W Trawick
April 1985, Clinical chemistry,
I Vlahos, and W MacMahon, and D Sgoutas, and W Bowers, and J Thompson, and W Trawick
October 1961, The Australian journal of experimental biology and medical science,
I Vlahos, and W MacMahon, and D Sgoutas, and W Bowers, and J Thompson, and W Trawick
October 1969, Comptes rendus hebdomadaires des seances de l'Academie des sciences. Serie D: Sciences naturelles,
I Vlahos, and W MacMahon, and D Sgoutas, and W Bowers, and J Thompson, and W Trawick
January 1984, Voprosy meditsinskoi khimii,
I Vlahos, and W MacMahon, and D Sgoutas, and W Bowers, and J Thompson, and W Trawick
March 1959, Journal of clinical pathology,
I Vlahos, and W MacMahon, and D Sgoutas, and W Bowers, and J Thompson, and W Trawick
August 1983, Clinical biochemistry,
I Vlahos, and W MacMahon, and D Sgoutas, and W Bowers, and J Thompson, and W Trawick
September 2001, Fertility and sterility,
Copied contents to your clipboard!